The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-AstraZeneca, commodity stocks drag down UK's FTSE 100

Fri, 12th Nov 2021 10:36

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* AstraZeneca slumps after profit miss

* Miners, oil stocks weigh after dollar dents commodity
prices

* FTSE 100 down 0.5%, FTSE 250 ends flat
(Updates to close)

By Bansari Mayur Kamdar

Nov 12 (Reuters) - UK's FTSE 100 index fell on Friday,
dragged lower by drugmaker AstraZeneca following its profit
miss, while commodity-linked stocks slipped as a stronger dollar
dented metal and oil prices.

The blue-chip FTSE 100 index ended 0.5% lower,
weighed by AstraZeneca after the COVID-19 vaccine maker
reported a smaller-than-expected quarterly profit and stuck with
its overall profit forecast for the year.

"Such guidance from the leading vaccine provider, at a time
when nations are already inoculating vulnerable patients with a
booster dose, certainly charts a gloomy path for profitability
in upcoming quarters," said Kunal Sawhney, CEO of Kalkine group.

A 2.6% drop in mining stocks and 1.2% slide
in energy stocks also dragged down the
commodity-heavy FTSE 100 index as a stronger dollar weighed on
commodity prices on bets of an earlier-than-expected interest
rate.

However, the surge in mining stocks earlier in the week put
the FTSE 100 on track for its third consecutive week of gains.

Bogged down by inflationary pressures and supply chain
problems, UK blue-chip shares continue to underperform their
European peers. The FTSE 100 has gained just 13.9% this year
compared to the 21.7% increase in the pan-European STOXX 600
index.

According to a latest Chambers of Commerce survey, 80% of
businesses are feeling the effects from price increases in the
UK, adding to fears of inflation in the market, Bloomberg News
reported. (bit.ly/30lg4FP)

In a bright spot, there were reports suggesting Britain
wanted to de-escalate tensions with the European Union and renew
efforts to find a solution over a Northern Ireland trade
dispute.

The domestically-focussed mid-cap index ended flat
with financials and consumer discretionary stocks among the
worst performers.

Online trading platform IG Group slipped 1.4% after
completion of a comprehensive refinancing of its debt, providing
it with additional financial flexibility to grow.

(Reporting by Bansari Mayur Kamdar and Amal S in Bengaluru;
Editing by Shailesh Kuber and Krishna Chandra Eluri)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.